Innovative science is the first step to getting a drug to market. However, science alone is not enough – a company needs an optimal development strategy as well as the ability to execute it. S3B was founded to support biotech startups, venture capital and private equity firms identify and manage key elements of strategic and operational risk affecting value and ROI. S3B are experts in translating science to strategy. Specializations include: • Pharmaceutical Strategy Assessment, Development and Optimization • Pricing and Reimbursement Strategy • Probability of Technical and Regulatory Success Assessment • Milestone Risk Assessment • Risk Mitigation Planning • Resource Development and Planning